发明名称 |
Use of anti-CD45 leukocyte antigen antibodies for immunomodulation |
摘要 |
A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.
|
申请公布号 |
US6106834(A) |
申请公布日期 |
2000.08.22 |
申请号 |
US19960715342 |
申请日期 |
1996.09.18 |
申请人 |
RESEARCH CORPORATION TECHNOLOGIES, INC. |
发明人 |
LAZAROVITS, ANDREW I.;POPPEMA, SIBRAND |
分类号 |
C12N15/09;A61K38/00;A61K39/395;A61P37/06;C07K16/28;C12P21/08;(IPC1-7):A61K39/395 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|